Boosted REYATAZ Proves As Effective In Women Living With HIV As Men

Bristol-Myers Squibb Company announced results from a long-term, retrospective, European cohort study, which included 1,294 antiretroviral (ARV)-experienced patients (336 female and 958 male) from Germany, France and Sweden, that were presented at the Sixth International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011)…

Study Integrating Family Planning And HIV Treatment & Care Funded By The Bill & Melinda Gates Foundation

UCSF has received a $1.15 million grant from the Bill & Melinda Gates Foundation to determine if integrating family planning into HIV treatment and care will increase contraceptive use and decrease unintended pregnancy among HIV-positive women. UCSF will partner with the Kenya Medical Research Institute and Ibis Reproductive Health to conduct the research…

Also In Global Health News: Home HIV Treatment; Voluntary Testing In Kenya; Women/HIV Scorecard; Global Fund Zimbabwe Grant; Contraceptives In Tanzani

Home Vs. Clinic Treatment of HIV In Uganda The New York Times reports on a Lancet study that found treating Ugandan HIV patients at home is cheaper and just as effective as treating them in a clinic.